NASDAQ:CBPO
Delisted
China Biologic Products Stock News
$119.99
+0 (+0%)
At Close: May 27, 2022
China Biologic Announces Completion of Going Private Transaction
04:30pm, Tuesday, 20'th Apr 2021
BEIJING, April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
04:30pm, Monday, 29'th Mar 2021
BEIJING, March 29, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in C
China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q3 2020 Results - Earnings Call Transcript
09:29pm, Wednesday, 25'th Nov 2020
China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q3 2020 Results - Earnings Call Transcript
China Biologic Products to Report Third Quarter 2020 Financial Results
08:00am, Friday, 13'th Nov 2020
BEIJING, Nov. 13, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in C
China Biologic Products Inc (CBPO) Q2 2020 Earnings Call Transcript
08:00pm, Tuesday, 18'th Aug 2020
An earnings release is available on the Company's website. Today, you will hear from China Biologic's Chairman and CEO, Mr. Joseph Chow, who will start off the call with a review of the Company's ope
China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q2 2020 Results - Earnings Call Transcript
12:49pm, Tuesday, 18'th Aug 2020
China Biologic Products Holdings, Inc. (NASDAQ:CBPO) Q2 2020 Results Earnings Conference Call August 18, 2020, 07:30 AM ET Company Participants Philip Lisio - The Foote Group Joseph Chow - Chairman an
China Biologic Reports Financial Results for the Second Quarter of 2020
08:30pm, Monday, 17'th Aug 2020
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited fina
The Week Ahead In Biotech: Spotlight On Gilead, BioMarin FDA Decisions, IPOs
12:30pm, Sunday, 16'th Aug 2020
Biotech stocks came under pressure in the week ended Aug. 14 amid mixed earnings news flow from the sector. FDA decisions scheduled for the week also produced adverse outcomes. Eagle Pharmaceuticals I
China Biologic Products to Report Second Quarter 2020 Financial Results
12:00pm, Monday, 10'th Aug 2020
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company
5 Profitable Companies With a Margin of Safety
04:45pm, Monday, 13'th Jul 2020
Comcast makes the list Continue reading...
5 Health Care Stocks Boosting Earnings
03:18pm, Tuesday, 30'th Jun 2020
Biogen tops the list Continue reading...
China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction
05:00am, Monday, 29'th Jun 2020
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today declared that the Company di
Hedge Funds Are Selling China Biologic Products Holdings Inc (CBPO)
04:55pm, Friday, 26'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
China Biologic Products Inc (CBPO) Q1 2020 Earnings Call Transcript
08:00pm, Thursday, 21'st May 2020
An earnings release is available on the Company's website. Today, you will hear from China Biologic's Chairman and CEO, Mr. Joseph Chow, who will start off the call with a review of the Company's bas
